Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination. - Test2 - elhamkhani - TriplyDB

Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.

Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.

http://www.wikidata.org/entity/Q37514807

about

Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system.Myelination and mTOR.Treating pediatric neuromuscular disorders: The future is now.

P2860

Q41560440-632754A0-33A3-43F0-BA03-D5CA3B6182B1 Q48170239-7080589B-517A-41A8-A9CB-9831447F905D Q52756417-1A88D8A4-CC7B-4D31-905B-E5197088E20E

P2860

Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.

http://www.wikidata.org/entity/Q37514807

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.

@en

Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.

@nl

type

label

Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.

@en

Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.

@nl

prefLabel

Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.

@en

Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.

@nl

P1433

Q37514807-4F52D6E4-8988-4392-A7DF-37D68C2A24B0

P1476

Q37514807-5CF39D9F-D2FB-43A1-A490-C20A55E57C34

P2093

Q37514807-2A7F0E50-4BA0-478B-BEB7-5F940B4D9A81

Q37514807-B1F3B627-A103-4955-8095-0EFAEC5036C5

Q37514807-BAE5A281-BAC1-47B5-9122-F2741C973FC6

Q37514807-DF63D7C6-8664-41CB-829D-250B5C5E91FA

Q37514807-E54A8FB5-5002-48EF-9641-E4375C477D4E

Q37514807-EF2FCA97-0481-4F21-AA2B-21C26C3C8627

P2860

Q37514807-0FF37A23-ED5D-44F9-A28E-FEDD9605E727

Q37514807-12EDA75D-7B42-4373-AE3F-1F42D0EE372F

Q37514807-1D362DC0-E081-470D-9660-A841676E0D78

Q37514807-29F98999-9310-4DDF-BF5C-13FCA0E7E577

Q37514807-2C73FA24-1319-4F32-B7F1-AEE5F7F9E9EB

Q37514807-2D0AD966-387E-44BA-8EBD-CCD70113D2E0

Q37514807-337BCE15-F1D5-413C-89C8-DE7E53E39AF3

Q37514807-44B171FB-2831-47AB-9674-D0EB5DDD3664

Q37514807-47418C11-4B76-4EFE-AC82-CC6A03DB0C12

Q37514807-572FE03E-4441-45D3-BBC1-C48911A7FE45

P304

Q37514807-B0850FD5-9B62-4AF2-AF57-D5A20D208926

P31

Q37514807-C47C6902-F3A5-4451-BA44-2C819B5EC23F

P356

Q37514807-108EDFBA-D6F8-4F53-A3EC-3B2DC6DD44EA

P433

Q37514807-890528B6-BC9F-471A-AF40-0C484129637C

P478

Q37514807-D2104703-9A3A-4DED-A737-45CA2CBAA924

P50

Q37514807-2622A0EB-A11A-4D49-B67F-5BCBCD3968A9

Q37514807-46D0BC91-5A1A-4C8C-8D5F-411E2F341059

Q37514807-49FE7084-077A-4191-80AA-9EA66B0FF2E8

Q37514807-ADFC9351-B656-4C05-B3DE-E0320AD8612D

Q37514807-C0F6A91F-C3EE-4965-8013-91702ABA64C2

Q37514807-D7BD990A-6F54-4A6E-8812-AE121252DBBD

P577

Q37514807-A3B1E387-41D3-4E58-B3EC-AABE8CDC8045

P698

Q37514807-1E922CD6-8B5A-4956-8A9B-EE68FBED667B

P932

Q37514807-2FBFC39C-7FF7-4DA8-A748-327DF076E36B

P356

P1433

EMBO Molecular Medicine

P1476

Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.

@en

P2093

Alessandro Nonis

http://www.w3.org/2001/XMLSchema#string

Carla Taveggia

http://www.w3.org/2001/XMLSchema#string

Cristina Rivellini

http://www.w3.org/2001/XMLSchema#string

Françoise Piguet

http://www.w3.org/2001/XMLSchema#string

Roberta Noseda

http://www.w3.org/2001/XMLSchema#string

Valeria Alberizzi

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphoinositides in cell regulation and membrane dynamics

Diagnosis, natural history, and management of Charcot–Marie–Tooth disease

Nutritional or pharmacological activation of HCA(2) ameliorates neuroinflammation

Control of peripheral nerve myelination by the beta-secretase BACE1

Random-effects models for longitudinal data

Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies

Axonal neuregulin-1 regulates myelin sheath thickness

Sh3tc2 deficiency affects neuregulin-1/ErbB signaling

Dlg1, Sec8, and Mtmr2 regulate membrane homeostasis in Schwann cell myelination

Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration

P304

1438-1454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15252/EMMM.201606349

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Stefano C. Previtali

Alessandra Bolino

Patrizia D'Adamo

Marta Guerrero-Valero

Marta Pellegatta

P577

2016-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27799291

http://www.w3.org/2001/XMLSchema#string

P932

5167133

http://www.w3.org/2001/XMLSchema#string